At the BIA’s annual conference, industry executives discussed the UK’s position as a leader in bioprocessing and what steps must be taken to keep pace with global innovation.
How to best safeguard the biopharmaceutical supply chain? What more can be done to reduce the cost of medicines? This and more was discussed at the Annual bioProcess UK Conference this week in Scotland.
BIA’s Bioscience Forum brought together four experts on cell and gene manufacture to discuss what difficulties are being faced in the industry and how they are reacting to them.
